Cargando…
Erratum: Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561368/ https://www.ncbi.nlm.nih.gov/pubmed/28798079 http://dx.doi.org/10.1136/annrheumdis-2016-210094corr1 |
| _version_ | 1783257828980424704 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5561368 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55613682017-11-16 Erratum: Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study Ann Rheum Dis Miscellaneous BMJ Publishing Group 2017-09 2017-08-10 /pmc/articles/PMC5561368/ /pubmed/28798079 http://dx.doi.org/10.1136/annrheumdis-2016-210094corr1 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| spellingShingle | Miscellaneous Erratum: Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study |
| title | Erratum: Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study |
| title_full | Erratum: Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study |
| title_fullStr | Erratum: Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study |
| title_full_unstemmed | Erratum: Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study |
| title_short | Erratum: Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study |
| title_sort | erratum: baricitinib in patients with inadequate response or intolerance to conventional synthetic dmards: results from the ra-build study |
| topic | Miscellaneous |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561368/ https://www.ncbi.nlm.nih.gov/pubmed/28798079 http://dx.doi.org/10.1136/annrheumdis-2016-210094corr1 |